S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
66,000% upside on tiny biotech? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
66,000% upside on tiny biotech? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
66,000% upside on tiny biotech? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Even at $2,000+ Per Share, These 3 Stocks Are Deals
66,000% upside on tiny biotech? (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
66,000% upside on tiny biotech? (Ad)
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
Tax Software Specialist Vertex In Buy Zone After Base Breakout
NYSE:VHAQ

Viveon Health Acquisition (VHAQ) Stock Forecast, Price & News

$11.09
0.00 (0.00%)
(As of 06/9/2023 ET)
Compare
Today's Range
$11.09
▼
$11.09
50-Day Range
$10.94
▼
$11.09
52-Week Range
$7.85
▼
$12.12
Volume
300 shs
Average Volume
232 shs
Market Capitalization
$76.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media

VHAQ stock logo

About Viveon Health Acquisition (NYSE:VHAQ) Stock

Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Norcross, Georgia. Viveon Health Acquisition Corp. operates as a subsidiary of Viveon Health LLC.

Receive VHAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Viveon Health Acquisition and its competitors with MarketBeat's FREE daily newsletter.

VHAQ Stock News Headlines

June 6, 2023 | americanbankingnews.com
Reviewing Viveon Health Acquisition (NYSE:VHAQ) & Reata Pharmaceuticals (NASDAQ:RETA)
April 25, 2023 | finance.yahoo.com
VIVEON HEALTH ACQUISITION CORP. RECEIVES NYSE NOTICE REGARDING DELAYED FORM 10-K FILING
June 10, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
April 18, 2023 | finance.yahoo.com
Viveon Health Acquisition Corp. (VHAQ-RT)
April 12, 2023 | finance.yahoo.com
(Updated) Clearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate Innovative Longevity-Tech Platform to Market
April 6, 2023 | seekingalpha.com
SPAC Viveon to merge with senior-care tech provider Clearday
March 1, 2023 | msn.com
SPAC Viveon signs merger LOI with health monitoring platform Clearday
March 1, 2023 | finance.yahoo.com
Viveon Health Acquisition Corp. and Clearday Inc. Announce Signed Letter of Intent to Merge and Create a Leading Longevity Care Company
June 10, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
February 6, 2023 | msn.com
SPAC Viveon terminates planned merger with Suneva Medical
February 3, 2023 | finance.yahoo.com
Viveon Health Acquisition Corp. Announces Termination of Merger Agreement with Suneva Medical, Inc.
January 25, 2023 | msn.com
SPAC Viveon Health delays Suneva merger vote amid cash issues
January 25, 2023 | finance.yahoo.com
VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of Special Meeting in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Until February 3, 2023.
December 21, 2022 | finance.yahoo.com
VIVEON HEALTH ACQUISITION CORP. Announces that Redemption Reversals in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Are Extended Until December 23, 2022.
November 6, 2022 | investing.com
DTRT Health Acquisition Corp Unit (DTRTU)
September 17, 2022 | wsj.com
Viveon Health Acquisition Corp.
September 13, 2022 | finance.yahoo.com
Suneva Medical Launches 30 mL PRP Gel Tubes of Amplifine, Allowing for More Variety and Efficiency in PRP Treatments
August 6, 2022 | investing.com
VHAQ_u Historical Data
July 17, 2022 | yahoo.com
My boyfriend gave me a list of all the things he didn't like about me. It was our first breakup of many.
July 15, 2022 | finance.yahoo.com
Viveon Health Acquisition Corp. Announces Filing of Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Suneva Medical
July 6, 2022 | finance.yahoo.com
Viveon Health Acquisition Corp. (VHAQ)
See More Headlines

VHAQ Price History

VHAQ Company Calendar

Today
6/09/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:VHAQ
CUSIP
N/A
CIK
1823857
Web
N/A
Phone
404-861-5393
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.49 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-4.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.07
Quick Ratio
0.07

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.50 per share
Price / Cash Flow
22.17
Book Value
($2.58) per share
Price / Book
-4.30

Miscellaneous

Outstanding Shares
6,880,000
Free Float
1,845,000
Market Cap
$76.30 million
Optionable
Not Optionable
Beta
0.01

Key Executives

  • Dr. Jagi Gill M.D. (Age 58)
    Ph.D., CEO, Pres & Chairman
  • Dr. Romilos Papadopoulos M.D. (Age 64)
    CFO, Treasurer, Sec. & Director

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













VHAQ Stock - Frequently Asked Questions

How have VHAQ shares performed in 2023?

Viveon Health Acquisition's stock was trading at $10.65 at the beginning of 2023. Since then, VHAQ shares have increased by 4.1% and is now trading at $11.0901.
View the best growth stocks for 2023 here.

What is Viveon Health Acquisition's stock symbol?

Viveon Health Acquisition trades on the New York Stock Exchange (NYSE) under the ticker symbol "VHAQ."

Who are Viveon Health Acquisition's major shareholders?

Viveon Health Acquisition's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Mizuho Securities USA LLC (4.78%).

How do I buy shares of Viveon Health Acquisition?

Shares of VHAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Viveon Health Acquisition's stock price today?

One share of VHAQ stock can currently be purchased for approximately $11.09.

How much money does Viveon Health Acquisition make?

Viveon Health Acquisition (NYSE:VHAQ) has a market capitalization of $76.30 million.

How can I contact Viveon Health Acquisition?

Viveon Health Acquisition's mailing address is 3953 HOLCOMB BRIDGE ROAD SUITE 200, NORCROSS GA, 30092. The company can be reached via phone at 404-861-5393.

This page (NYSE:VHAQ) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -